These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3129525)

  • 1. Production of gamma interferon by cultured human lymphocytes stimulated with a purified membrane protein (P30) from Toxoplasma gondii.
    Khan IA; Eckel ME; Pfefferkorn ER; Kasper LH
    J Infect Dis; 1988 May; 157(5):979-84. PubMed ID: 3129525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular immune responses to recombinant antigens in pregnant women chronically infected with Toxoplasma gondii.
    Fatoohi AF; Cozon GJ; Greenland T; Ferrandiz J; Bienvenu J; Picot S; Peyron F
    Clin Diagn Lab Immunol; 2002 May; 9(3):704-7. PubMed ID: 11986281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells.
    Nagineni CN; Pardhasaradhi K; Martins MC; Detrick B; Hooks JJ
    Infect Immun; 1996 Oct; 64(10):4188-96. PubMed ID: 8926087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of an indoleamine 2,3-dioxygenase induced by gamma-interferon in cultured human fibroblasts.
    Pfefferkorn ER; Rebhun S; Eckel M
    J Interferon Res; 1986 Jun; 6(3):267-79. PubMed ID: 2427623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to Toxoplasma gondii major surface protein (SAG-1, P30) inhibit infection of host cells and are produced in murine intestine after peroral infection.
    Mineo JR; McLeod R; Mack D; Smith J; Khan IA; Ely KH; Kasper LH
    J Immunol; 1993 May; 150(9):3951-64. PubMed ID: 7682587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-induced human interferon-gamma production. Differential dependence on interleukin 2 and its receptor.
    Kelly CD; Welte K; Murray HW
    J Immunol; 1987 Oct; 139(7):2325-8. PubMed ID: 2958545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in vitro model for Toxoplasma infection in man. Interaction between CD4+ monoclonal T cells and macrophages results in killing of trophozoites.
    Canessa A; Pistoia V; Roncella S; Merli A; Melioli G; Terragna A; Ferrarini M
    J Immunol; 1988 May; 140(10):3580-8. PubMed ID: 3129496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of antigen-specific parasiticidal cytotoxic T cell splenocytes by a major membrane protein (P30) of Toxoplasma gondii.
    Khan IA; Smith KA; Kasper LH
    J Immunol; 1988 Nov; 141(10):3600-5. PubMed ID: 2460541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA vaccine encoding the Toxoplasma gondii bradyzoite-specific surface antigens SAG2CDX protect BALB/c mice against type II parasite infection.
    Zhang M; Zhao L; Song J; Li Y; Zhao Q; He S; Cong H
    Vaccine; 2013 Sep; 31(41):4536-40. PubMed ID: 23933373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.
    Zheng B; Lu S; Tong Q; Kong Q; Lou D
    Vaccine; 2013 Sep; 31(41):4578-84. PubMed ID: 23928460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxoplasma gondii antigens GRA1 (p24) and SAG1 (p30): a comparison of their stimulatory influence on T-cell activation and cytokine expression in in vitro cultures.
    Kato M; Claveria FG; Maki Y; Tanaka T; Suzuki N; Nagasawa H
    Pathobiology; 2005; 72(3):160-4. PubMed ID: 15860934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-Gamma Release Assay: An Effective Tool to Detect Early Toxoplasma gondii Infection in Mice.
    Yin Q; El-Ashram S; Liu H; Sun X; Zhao X; Liu X; Suo X
    PLoS One; 2015; 10(9):e0137808. PubMed ID: 26378802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A purified parasite antigen (p30) mediates CD8+ T cell immunity against fatal Toxoplasma gondii infection in mice.
    Khan IA; Ely KH; Kasper LH
    J Immunol; 1991 Nov; 147(10):3501-6. PubMed ID: 1940350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
    Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
    Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer.
    Subauste CS; Wessendarp M; Sorensen RU; Leiva LE
    J Immunol; 1999 Jun; 162(11):6690-700. PubMed ID: 10352287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine.
    Gazzinelli RT; Hakim FT; Hieny S; Shearer GM; Sher A
    J Immunol; 1991 Jan; 146(1):286-92. PubMed ID: 1670604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Toxoplasma gondii: the characterization of an anti-P30 monoclonal antibody].
    Fachado A; Fernández N; Hernández E; Fonseca L
    Rev Cubana Med Trop; 1996; 48(3):178-83. PubMed ID: 9805047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of increased indoleamine 2,3-dioxygenase activity attenuates Toxoplasma gondii replication in the lung during acute infection.
    Murakami Y; Hoshi M; Hara A; Takemura M; Arioka Y; Yamamoto Y; Matsunami H; Funato T; Seishima M; Saito K
    Cytokine; 2012 Aug; 59(2):245-51. PubMed ID: 22609210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell profiles elicited by Toxoplasma gondii in acutely/chronically infected humans.
    Silva-Gutierrez N; Bahsas Zaky R; Bouchard M; Teran Angel G; Amoroso A; Peterson DL; Salmen S
    Parasite Immunol; 2018 Jun; 40(6):e12532. PubMed ID: 29633283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strain- and Dose-Dependent Reduction of
    Jennes M; De Craeye S; Devriendt B; Dierick K; Dorny P; Cox E
    Front Cell Infect Microbiol; 2017; 7():232. PubMed ID: 28642841
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.